| 标题 |
 Safety, tolerability and preliminary efficacy of QLP2117, a novel CCR8 antibody, in patients with advanced solid tumors: results from a dose-escalation phase 1a clinical trial |
| 网址 | |
| DOI |
10.1136/jitc-2024-SITC2024.1498
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
XX
Criminology34
Dong021
Kao
GingerF
leery
OK
无极微光
Logan
null
独特的项链
谪仙
mmyhn
有人
W sir
GODV
heekkll
好好
皖公网安备34019202002308
